Viewing nowOlmesartan Medoxomil 40mg Tablet
Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Kunil Biopharm Co., Ltd.

MFDS item code 202002275 · Approved 2020.04.01 · Insurance code 073001210
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is persistently high without a specific cause. This medication helps treat essential hypertension, stabilize blood pressure, and prevent complications in the cardiovascular system. Regular intake along with lifestyle improvements is important, and controlling blood pressure helps improve overall health. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect in approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the medicine at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. No overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients allergic to this drug or its ingredients, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with severe liver impairment, patients with biliary obstruction, and patients with lactose intolerance should not take this medication. Patients with reduced blood volume or salt may experience hypotension; thus, their condition should be closely monitored before starting treatment, and appropriate measures should be taken if hypotension occurs. Patients with impaired renal function or kidney transplant recipients may experience changes in renal function while taking this medication, so regular blood tests should be done to check kidney status. Patients at risk of hyperkalemia, especially those with heart failure or renal impairment, should have their serum potassium levels tested periodically. Patients with aortic stenosis or mitral valve stenosis, and those with obstructive heart disease should be particularly cautious when taking this medication. Due to its blood pressure-lowering effects, this medication may cause dizziness; thus, it is advisable to avoid hazardous activities such as working at heights or operating machinery. Combining this medication with potassium-sparing diuretics or potassium supplements may dangerously elevate serum potassium levels, so caution is warranted. Taking this medication together with non-steroidal anti-inflammatory drugs may worsen renal function, so adequate hydration should be ensured, and kidney function monitored regularly. Avoid using this medication in conjunction with lithium preparations, as it may lead to elevated lithium levels and toxicity. Taking this medication during pregnancy may result in serious problems for the fetus, such as hypotension, renal functions decline, or impaired skull development, so it should be discontinued immediately upon discovering pregnancy. Breastfeeding women should discontinue breastfeeding or this medication, as it may affect the baby through breast milk. Safety and efficacy in children have not yet been established. Elderly patients may have higher concentrations of this medication in their body compared to younger individuals, so caution is necessary when dosing. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, requiring appropriate treatment based on symptoms. This medication is known to have a low risk of carcinogenicity or genotoxicity even with long-term use, but any abnormal symptoms that occur during treatment should be reported to a healthcare professional immediately.
Dizziness, low back pain, bronchitis, increased creatine phosphokinase, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, cough, chest pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastroenteritis, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, chronic malabsorption-like intestinal disease, intestinal vascular edema, rhabdomyolysis, hyperkalemia, acute renal failure, elevated serum creatinine, hair loss, pruritus, urticaria, autoimmune hepatitis, postural dizziness, palpitations, hypertension, increased serum creatinine, epistaxis, upper respiratory tract infection, asthma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain storage temperatures between 1 and 25 degrees Celsius at room temperature. Proper storage will help preserve the medication's efficacy for a long time.
White rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 40mg
Tablet · Prescription medication
Kunil Biopharm Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.